COVID-19 Epidemiology
Sort by:
Cleveland Clinic Rheumatology
Vaccine Responses in Immune-Mediated Inflammatory Diseases: Challenges and Strategies
FEATURING
Alfred Kim
- 173 views
- July 22, 2022
- 1
Cleveland Clinic Rheumatology
Breakthrough COVID-19 in Immune-Mediated Inflammatory Diseases
FEATURING
Jeff Sparks
- 39 views
- July 22, 2022
Cleveland Clinic Rheumatology
The Epidemic Long COVID-19: Questions, Implications for Rheumatology
FEATURING
Leonard Calabrese
- 116 views
- July 22, 2022
Cleveland Clinic Rheumatology
COVID-19 Autoimmunity, Prevention and Management: Q&A
- 65 views
- July 22, 2022
Cleveland Clinic Rheumatology
Rheumatic Diseases and COVID-19: Challenges for Science in February 2022
FEATURING
Leonard Calabrese
- 7 views
- July 22, 2022
Cleveland Clinic Rheumatology
Disease Related Factors and the Risk of Infection Acquisition and Disease Progression
FEATURING
Richard Conway
- 7 views
- July 22, 2022
Cleveland Clinic Rheumatology
COVID-19 and the Risks From Immunomodulatory Therapies
FEATURING
Zachary Wallace
- 61 views
- July 22, 2022
Cleveland Clinic Rheumatology
Rheumatic Diseases and COVID-19: February 2022 Q&A
- 12 views
- July 22, 2022
Columbia University's Zuckerman Institute
Evolution of SARS-CoV-2 – Delta, Omicron, and More Greek Alphabet(s)
FEATURING
Kei Sato
- 383 views
- May 20, 2022
- 2
Columbia University's Zuckerman Institute
Tracking SARS-CoV-2 Variants in the UK
FEATURING
Emma Thomson
- 16 views
- April 19, 2022
Columbia University's Zuckerman Institute
Exosomal ACE2 Neutralizes Broad Variants of SARS-CoV-2
FEATURING
Lamiaa El-Shennawy
- 7 views
- April 19, 2022
Monica Gandhi
COVID-19 Endemicity: What Will Endemic Stage and Rational Roadmap to Future Covid Management Look Like?
- 4,510 views
- April 19, 2022
- 25
Columbia University's Zuckerman Institute
SARS-CoV-2 Variants Alpha to Omicron: The Response of T-Cells
FEATURING
Alba Grifoni
- 23 views
- March 22, 2022
- 1
Columbia University's Zuckerman Institute
T-Cell Responses in Acute and Persistent COVID-19
FEATURING
Alexander Huang
- 4 views
- March 22, 2022